4//SEC Filing
Yan Ming 4
Accession 0001874041-25-000002
CIK 0001831915other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 7:09 PM ET
Size
26.0 KB
Accession
0001874041-25-000002
Insider Transaction Report
Form 4
Yan Ming
DirectorCHIEF TECHNOLOGY OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-11-18+1,981→ 6,059,400 total - Tax Payment
Common Stock
2025-11-18$5.53/sh−483$2,671→ 6,058,917 total - Exercise/Conversion
Common Stock
2025-11-18+7,363→ 6,066,280 total - Tax Payment
Common Stock
2025-11-18$5.53/sh−1,793$9,915→ 6,064,487 total - Exercise/Conversion
Common Stock
2025-11-18+6,162→ 6,074,828 total - Exercise/Conversion
Common Stock
2025-11-18+5,525→ 6,070,012 total - Exercise/Conversion
Restricted Stock Units
2025-11-18−5,525→ 51,569 total→ Common Stock (5,525 underlying) - Tax Payment
Common Stock
2025-11-18$5.53/sh−1,346$7,443→ 6,068,666 total - Tax Payment
Common Stock
2025-11-18$5.53/sh−1,501$8,301→ 6,073,327 total - Exercise/Conversion
Restricted Stock Units
2025-11-18−1,981→ 1,332 total→ Common Stock (1,981 underlying) - Exercise/Conversion
Restricted Stock Units
2025-11-18−7,363→ 39,277 total→ Common Stock (7,363 underlying) - Exercise/Conversion
Restricted Stock Units
2025-11-18−6,162→ 82,175 total→ Common Stock (6,162 underlying)
Footnotes (6)
- [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
- [F3]The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
- [F4]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2024 and each March 10 thereafter, until fully vested.
- [F5]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter.
- [F6]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested.
Documents
Issuer
Cytek Biosciences, Inc.
CIK 0001831915
Entity typeother
Related Parties
1- filerCIK 0001874041
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 7:09 PM ET
- Size
- 26.0 KB